Hyster-Yale (HY) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 consolidated revenues were $956.6M–$957M, down 18–19% year-over-year but up 5% sequentially, driven by lower volumes, pricing pressures, and tariff-related uncertainty, especially in the Americas and EMEA.
Operating loss was $8.5M, with adjusted operating profit at $5M–$7.2M, both down sharply from Q2 2024; net loss attributable to stockholders was $13.9M, adjusted net loss $2M–$2.3M.
Bookings dropped to $330M from $590M in Q1, with order backlog falling to $1.7B, reflecting shipment outpacing new orders and ongoing demand softness, especially in EMEA and the Americas.
Management is prioritizing proactive customer engagement, flexible production, and inventory alignment to navigate economic and tariff volatility.
Renewed $300M revolving credit facility with improved terms and extended maturity to June 2030.
Financial highlights
Q2 2025 revenues: $956.6M–$957M (down 18–19% year-over-year, up 5% sequentially).
Adjusted operating profit: $5M–$7.2M; operating loss: $8.5M; adjusted EBITDA: $21M; net loss: $13.9M; adjusted net loss: $2M–$2.3M.
Gross profit: $168.2M (down 35% year-over-year); diluted EPS: $(0.79); adjusted diluted EPS: $(0.14).
Q2 product margins were negatively impacted by $10M in tariff-driven material and freight increases.
Q2 income tax expense was $200,000, down from $26M prior year, reflecting lower pre-tax earnings.
Outlook and guidance
Full-year 2025 revenues, production, and profits expected below 2024 due to tariffs, weaker demand, and competitive pressures.
Q3 2025 operating profit projected to improve sequentially, but full-year 2025 operating profit will decline significantly year-over-year and be slightly below previous guidance.
Tariffs are anticipated to negatively affect H2 2025 results, with mitigation efforts ongoing but unable to fully offset impacts.
Bolzoni's full-year 2025 revenues and profits are expected to decline year-over-year, with legacy product phase-out continuing.
Capital expenditures for 2025 are expected to be $50–$60M, with continued focus on manufacturing efficiency and technology upgrades.
Latest events from Hyster-Yale
- Proxy covers director elections, executive pay, equity plan, and auditor, with strong governance focus.HY
Proxy filing24 Mar 2026 - Q4 2025 bookings surged despite revenue and profit declines, with recovery expected in 2026.HY
Q4 20255 Mar 2026 - Q2 2024 profit and margin surged on strong pricing and backlog, with a robust outlook ahead.HY
Q2 20242 Feb 2026 - Q3 revenue up, profit down; 2025 outlook signals lower earnings before 2026 recovery.HY
Q3 202416 Jan 2026 - Record 2024 results set the stage for a challenging 2025 amid market normalization.HY
Q4 202423 Dec 2025 - Proxy covers director elections, pay, auditor, and governance; Rankin family holds voting control.HY
Proxy Filing2 Dec 2025 - Q1 2025 revenues and profits fell, but bookings surged and strategic realignment is underway.HY
Q1 202521 Nov 2025 - Q3 2025 profit and revenue fell sharply on tariffs and weak demand, with a net loss reported.HY
Q3 202513 Nov 2025